Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Daniel Q Bach"'
Autor:
Laura C Cappelli, Bernice Kwong, Jarushka Naidoo, Jonathan Leventhal, Mario E Lacouture, Meghan J Mooradian, Douglas B Johnson, Justine Cohen, Aparna Hegde, Steven T Chen, Riley Fadden, Leyre Zubiri, Shawn Kwatra, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Yevgeniy R Semenov, Nicole R LeBoeuf, Krista M Rubin, Anna K Dewan, Alina Markova, Allireza Alloo, Daniel Q Bach, Amina Bougrine, Leeann Burton, Mariana Castells, Lauren Guggina, Victor Huang, Benjamin Kaffenberger, Daniela Kroshinsky, Cecilia Larocca, Jon McDunn, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Maxwell Sauder, Sheila Shaigany, Afreen Shariff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
With an increasing number of patients eligible for immune checkpoint inhibitors, the incidence of immune-related adverse events (irAEs) is on the rise. Dermatologic immune-related adverse events (D-irAEs) are the most common and earliest to manifest,
Externí odkaz:
https://doaj.org/article/0f9ad47d419c4ad4b3131ec90c49be9f
Publikováno v:
Journal of the American Academy of Dermatology. 84:819-821
Publikováno v:
Journal of the American Academy of Dermatology. 84:568-570
Autor:
Nicole R. LeBoeuf, Victor Huang, Sameer Gupta, Robin Joyce, Ann S. LaCasce, Matthew S. Davids, Scott R. Granter, Anna K. Dewan, Saagar Jadeja, Daniel Q. Bach
Publikováno v:
JAAD Case Reports
JAAD case reports, vol 5, iss 5
JAAD case reports, vol 5, iss 5
Author(s): Dewan, Anna K; Gupta, Sameer; Bach, Daniel Q; Jadeja, Saagar; Granter, Scott; LaCasce, Ann; Joyce, Robin; Davids, Matthew S; Huang, Victor; LeBoeuf, Nicole R
Autor:
Steven T. Chen, Jason J. Yang, Jennifer T. Huang, Daniel Q. Bach, Sophia Sangar, Erin K. Collier
Publikováno v:
Pediatric dermatologyREFERENCES. 38(2)
Background Dermatologic conditions comprise a significant number of emergency department visits in the pediatric population in the United States. Understanding key predictors of emergency department utilization for dermatologic conditions is importan
Publikováno v:
Dermatologic Therapy. 33
Immune checkpoint inhibitors (ICI) improve the ability of the immune system to target cancer cells by blocking signaling through either the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death (PD-1) receptor, or its ligand (PD
Publikováno v:
Journal of the American Academy of Dermatology. 85(5)
Publikováno v:
Journal of the American Academy of Dermatology. 84(5)
Publikováno v:
International Journal of Dermatology. 59
The use of checkpoint inhibitors for treatment of advanced malignancies is increasing. Rashes, pruritus, and more rarely, reactions resembling Stevens-Johnsons syndrome (SJS) or toxic epidermal necrolysis (TEN) may occur secondary to checkpoint inhib
Autor:
Daniel Q. Bach, Jason J. Yang, Kyle Cheng, Kyle Tegtmeyer, Nolan J. Maloney, Jeffrey Zhao, Mindy M. Kim, Kevin A. Nguyen
Publikováno v:
International Journal of Dermatology. 59